Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chymases | 21 | 2020 | 28 | 5.850 |
Why?
|
| Angiotensin II | 21 | 2023 | 279 | 4.300 |
Why?
|
| Angiotensinogen | 16 | 2020 | 73 | 3.600 |
Why?
|
| Peptide Fragments | 19 | 2020 | 422 | 3.160 |
Why?
|
| Peptidyl-Dipeptidase A | 14 | 2020 | 142 | 1.960 |
Why?
|
| Myocardium | 10 | 2019 | 170 | 1.650 |
Why?
|
| Renin-Angiotensin System | 12 | 2020 | 182 | 1.610 |
Why?
|
| Angiotensins | 5 | 2020 | 49 | 1.580 |
Why?
|
| Myocytes, Cardiac | 6 | 2019 | 87 | 1.560 |
Why?
|
| Estrogens | 7 | 2020 | 162 | 1.350 |
Why?
|
| Organic Anion Transport Protein 1 | 5 | 2005 | 5 | 1.310 |
Why?
|
| Angiotensin I | 10 | 2019 | 262 | 1.310 |
Why?
|
| Iodine Radioisotopes | 3 | 2023 | 18 | 1.130 |
Why?
|
| Animals | 43 | 2020 | 7300 | 1.090 |
Why?
|
| Hypertension | 8 | 2019 | 910 | 0.870 |
Why?
|
| Methylmercury Compounds | 3 | 2005 | 7 | 0.810 |
Why?
|
| Rats | 21 | 2019 | 1604 | 0.790 |
Why?
|
| Heart Diseases | 2 | 2018 | 99 | 0.730 |
Why?
|
| Carboxypeptidases A | 1 | 2019 | 2 | 0.720 |
Why?
|
| Kidney | 7 | 2012 | 486 | 0.710 |
Why?
|
| Heart Atria | 3 | 2020 | 62 | 0.710 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 248 | 0.690 |
Why?
|
| Rats, Inbred SHR | 10 | 2019 | 42 | 0.630 |
Why?
|
| Heart Ventricles | 4 | 2020 | 107 | 0.630 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 162 | 0.630 |
Why?
|
| Mast Cells | 6 | 2019 | 17 | 0.580 |
Why?
|
| Diabetic Retinopathy | 1 | 2017 | 64 | 0.570 |
Why?
|
| Epithelial Cells | 3 | 2005 | 138 | 0.550 |
Why?
|
| Receptors, G-Protein-Coupled | 7 | 2019 | 89 | 0.530 |
Why?
|
| Homocysteine | 2 | 2005 | 15 | 0.520 |
Why?
|
| Heart Failure | 5 | 2019 | 571 | 0.520 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 72 | 0.510 |
Why?
|
| Ventricular Function, Left | 5 | 2019 | 195 | 0.510 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 77 | 0.510 |
Why?
|
| Cytochrome P-450 CYP1A1 | 3 | 2008 | 8 | 0.490 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2019 | 83 | 0.480 |
Why?
|
| Cysteine | 2 | 2005 | 131 | 0.480 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 6 | 2020 | 134 | 0.460 |
Why?
|
| Ventricular Remodeling | 6 | 2020 | 52 | 0.450 |
Why?
|
| Hydrolysis | 4 | 2019 | 38 | 0.420 |
Why?
|
| Humans | 29 | 2020 | 29147 | 0.410 |
Why?
|
| Proto-Oncogene Proteins | 7 | 2019 | 90 | 0.410 |
Why?
|
| Receptor, Angiotensin, Type 1 | 6 | 2019 | 75 | 0.400 |
Why?
|
| Substrate Specificity | 3 | 2019 | 84 | 0.400 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 136 | 0.380 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2008 | 6 | 0.360 |
Why?
|
| Cell Line | 7 | 2008 | 450 | 0.350 |
Why?
|
| Cell Survival | 6 | 2008 | 272 | 0.340 |
Why?
|
| Heart | 3 | 2016 | 162 | 0.340 |
Why?
|
| Chrysenes | 1 | 2008 | 1 | 0.340 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2008 | 6 | 0.340 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 55 | 0.330 |
Why?
|
| Ovariectomy | 4 | 2019 | 147 | 0.330 |
Why?
|
| p-Aminohippuric Acid | 5 | 2005 | 5 | 0.330 |
Why?
|
| Oxidative Stress | 3 | 2012 | 223 | 0.320 |
Why?
|
| Mercury | 2 | 2004 | 8 | 0.320 |
Why?
|
| Transfection | 6 | 2008 | 192 | 0.310 |
Why?
|
| Carcinogens | 2 | 2008 | 34 | 0.310 |
Why?
|
| Diastole | 4 | 2019 | 90 | 0.280 |
Why?
|
| Cacodylic Acid | 2 | 2003 | 2 | 0.280 |
Why?
|
| Amino Acid Transport Systems | 1 | 2005 | 1 | 0.270 |
Why?
|
| Acetylcysteine | 1 | 2005 | 11 | 0.270 |
Why?
|
| DNA Damage | 2 | 2003 | 88 | 0.260 |
Why?
|
| Dogs | 4 | 2005 | 117 | 0.260 |
Why?
|
| Temperature | 4 | 2005 | 55 | 0.260 |
Why?
|
| Organomercury Compounds | 1 | 2004 | 1 | 0.250 |
Why?
|
| Biological Transport | 4 | 2005 | 62 | 0.250 |
Why?
|
| Male | 18 | 2020 | 17832 | 0.250 |
Why?
|
| Kidney Tubules | 1 | 2004 | 25 | 0.250 |
Why?
|
| Female | 15 | 2020 | 18189 | 0.250 |
Why?
|
| Leucine | 3 | 2013 | 24 | 0.250 |
Why?
|
| Tetrazoles | 3 | 2013 | 71 | 0.240 |
Why?
|
| Cells, Cultured | 2 | 2023 | 799 | 0.230 |
Why?
|
| Retinal Pigments | 1 | 2023 | 8 | 0.230 |
Why?
|
| Renin | 6 | 2013 | 112 | 0.230 |
Why?
|
| Cadmium | 1 | 2003 | 8 | 0.230 |
Why?
|
| Arsenic | 1 | 2003 | 5 | 0.230 |
Why?
|
| Epithelium | 1 | 2003 | 21 | 0.230 |
Why?
|
| DNA, Superhelical | 1 | 2002 | 1 | 0.220 |
Why?
|
| Blood Pressure | 8 | 2016 | 806 | 0.220 |
Why?
|
| Herbicides | 1 | 2002 | 4 | 0.220 |
Why?
|
| Fumarates | 2 | 2012 | 3 | 0.220 |
Why?
|
| Valine | 2 | 2012 | 17 | 0.220 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 21 | 0.220 |
Why?
|
| Amides | 2 | 2012 | 20 | 0.220 |
Why?
|
| Ferritins | 1 | 2002 | 46 | 0.220 |
Why?
|
| Antihypertensive Agents | 4 | 2013 | 342 | 0.210 |
Why?
|
| Rats, Inbred WKY | 4 | 2019 | 24 | 0.210 |
Why?
|
| Benzopyrans | 2 | 2012 | 7 | 0.210 |
Why?
|
| Sodium Chloride | 2 | 2012 | 24 | 0.210 |
Why?
|
| Cardiovascular System | 2 | 2020 | 39 | 0.210 |
Why?
|
| Ethanolamines | 2 | 2012 | 16 | 0.210 |
Why?
|
| Probenecid | 3 | 2005 | 3 | 0.200 |
Why?
|
| Iron | 1 | 2002 | 113 | 0.200 |
Why?
|
| Amino Acid Sequence | 2 | 2019 | 280 | 0.200 |
Why?
|
| Dicarboxylic Acids | 3 | 2005 | 8 | 0.200 |
Why?
|
| Glutarates | 3 | 2005 | 3 | 0.200 |
Why?
|
| Immunohistochemistry | 4 | 2020 | 519 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 641 | 0.190 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 980 | 0.180 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 22 | 0.180 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2019 | 2 | 0.180 |
Why?
|
| Cyclopentanes | 1 | 2019 | 17 | 0.180 |
Why?
|
| Quinolines | 1 | 2019 | 27 | 0.180 |
Why?
|
| Myeloid Cells | 1 | 2019 | 35 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2019 | 747 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2019 | 60 | 0.180 |
Why?
|
| Calcium Channels, L-Type | 1 | 2019 | 45 | 0.180 |
Why?
|
| Antigens, CD | 1 | 2019 | 100 | 0.180 |
Why?
|
| Calcium | 2 | 2018 | 297 | 0.170 |
Why?
|
| Liver | 1 | 2002 | 464 | 0.170 |
Why?
|
| Up-Regulation | 3 | 2017 | 183 | 0.170 |
Why?
|
| Patents as Topic | 1 | 2018 | 2 | 0.170 |
Why?
|
| Muscle Proteins | 1 | 2019 | 57 | 0.170 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 18 | 0.170 |
Why?
|
| Drug Design | 1 | 2018 | 44 | 0.170 |
Why?
|
| Rats, Transgenic | 5 | 2019 | 52 | 0.160 |
Why?
|
| Sex Factors | 1 | 2020 | 631 | 0.160 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 314 | 0.160 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2013 | 68 | 0.160 |
Why?
|
| Receptors, Angiotensin | 3 | 2017 | 77 | 0.160 |
Why?
|
| Dihydroxydihydrobenzopyrenes | 2 | 2007 | 2 | 0.150 |
Why?
|
| Mutagens | 2 | 2007 | 4 | 0.150 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 18 | 0.150 |
Why?
|
| Cardiotonic Agents | 1 | 2017 | 39 | 0.150 |
Why?
|
| Cromolyn Sodium | 1 | 2016 | 2 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2020 | 514 | 0.140 |
Why?
|
| Lisinopril | 2 | 2013 | 28 | 0.140 |
Why?
|
| Fibrosis | 2 | 2016 | 103 | 0.140 |
Why?
|
| Procollagen | 1 | 2016 | 6 | 0.140 |
Why?
|
| Uricosuric Agents | 2 | 2005 | 2 | 0.140 |
Why?
|
| Imidazoles | 2 | 2013 | 104 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2013 | 281 | 0.130 |
Why?
|
| Aorta | 1 | 2016 | 103 | 0.130 |
Why?
|
| Collagen | 2 | 2017 | 217 | 0.130 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 109 | 0.130 |
Why?
|
| Stroke | 1 | 2020 | 548 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2013 | 454 | 0.120 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2013 | 1 | 0.120 |
Why?
|
| Malabsorption Syndromes | 1 | 2013 | 3 | 0.120 |
Why?
|
| Neprilysin | 1 | 2013 | 32 | 0.110 |
Why?
|
| Middle Aged | 4 | 2020 | 10846 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 93 | 0.110 |
Why?
|
| Kallikrein-Kinin System | 1 | 2012 | 1 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2013 | 98 | 0.110 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 2008 | 2 | 0.100 |
Why?
|
| Mutagenicity Tests | 2 | 2008 | 2 | 0.100 |
Why?
|
| Protein Transport | 1 | 2011 | 74 | 0.100 |
Why?
|
| Reactive Oxygen Species | 2 | 2003 | 159 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2014 | 239 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 20 | 0.100 |
Why?
|
| Animals, Newborn | 1 | 2011 | 111 | 0.100 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2009 | 29 | 0.090 |
Why?
|
| Hemodynamics | 3 | 2017 | 148 | 0.090 |
Why?
|
| Feces | 2 | 2013 | 29 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 23 | 0.080 |
Why?
|
| Inflammation | 1 | 2012 | 508 | 0.080 |
Why?
|
| Rats, Inbred Lew | 3 | 2013 | 116 | 0.080 |
Why?
|
| Ventricular Pressure | 2 | 2019 | 5 | 0.080 |
Why?
|
| Time Factors | 3 | 2020 | 2001 | 0.080 |
Why?
|
| Heart Valve Diseases | 2 | 2020 | 25 | 0.080 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 1 | 0.080 |
Why?
|
| Benzo(a)pyrene | 1 | 2007 | 4 | 0.080 |
Why?
|
| DNA Adducts | 1 | 2007 | 13 | 0.080 |
Why?
|
| Benzopyrenes | 1 | 2007 | 1 | 0.080 |
Why?
|
| Heart Rate | 3 | 2016 | 315 | 0.080 |
Why?
|
| Echocardiography | 2 | 2020 | 140 | 0.080 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 28 | 0.080 |
Why?
|
| Myocardial Ischemia | 2 | 2020 | 83 | 0.080 |
Why?
|
| Aged | 3 | 2020 | 9494 | 0.070 |
Why?
|
| Mice | 3 | 2013 | 2371 | 0.070 |
Why?
|
| Tritium | 1 | 2005 | 17 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2005 | 33 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 320 | 0.070 |
Why?
|
| Amino Acids | 1 | 2005 | 41 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2019 | 666 | 0.060 |
Why?
|
| Mercury Poisoning, Nervous System | 1 | 2004 | 2 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2004 | 5 | 0.060 |
Why?
|
| Oocytes | 1 | 2004 | 21 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 3719 | 0.060 |
Why?
|
| Digestive System | 1 | 2003 | 3 | 0.060 |
Why?
|
| Methylation | 1 | 2003 | 5 | 0.060 |
Why?
|
| Absorption | 1 | 2003 | 15 | 0.060 |
Why?
|
| Enterocytes | 1 | 2003 | 6 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2003 | 18 | 0.060 |
Why?
|
| Free Radicals | 1 | 2003 | 10 | 0.060 |
Why?
|
| Pentetic Acid | 1 | 2002 | 2 | 0.050 |
Why?
|
| Iron Chelating Agents | 1 | 2002 | 8 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2002 | 67 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2003 | 74 | 0.050 |
Why?
|
| Random Allocation | 2 | 2013 | 213 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2016 | 347 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2016 | 103 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 273 | 0.050 |
Why?
|
| Adult | 1 | 2013 | 8441 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 20 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 62 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2019 | 67 | 0.040 |
Why?
|
| Isoproterenol | 1 | 2019 | 18 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 76 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 172 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 160 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 59 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 165 | 0.040 |
Why?
|
| Cricetinae | 2 | 2007 | 58 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 89 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2019 | 279 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 196 | 0.040 |
Why?
|
| Infusions, Subcutaneous | 1 | 2016 | 5 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2016 | 23 | 0.040 |
Why?
|
| Rats, Inbred BN | 1 | 2016 | 32 | 0.040 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2016 | 1 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 125 | 0.040 |
Why?
|
| Phagosomes | 1 | 2016 | 4 | 0.040 |
Why?
|
| Homozygote | 1 | 2016 | 57 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2016 | 30 | 0.030 |
Why?
|
| Autophagy | 1 | 2016 | 53 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 290 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 481 | 0.030 |
Why?
|
| Rodentia | 1 | 2014 | 10 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 735 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 226 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 629 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 31 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2013 | 1 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 350 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2013 | 6 | 0.030 |
Why?
|
| Arabs | 1 | 2013 | 5 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2013 | 51 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 85 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 248 | 0.030 |
Why?
|
| Aldosterone | 1 | 2013 | 28 | 0.030 |
Why?
|
| Estradiol | 1 | 2013 | 118 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1108 | 0.030 |
Why?
|
| Telemetry | 1 | 2012 | 27 | 0.030 |
Why?
|
| Gelatinases | 1 | 2012 | 1 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2012 | 4 | 0.030 |
Why?
|
| Receptors, Bradykinin | 1 | 2012 | 3 | 0.030 |
Why?
|
| Aprotinin | 1 | 2012 | 6 | 0.030 |
Why?
|
| Extracellular Fluid | 1 | 2012 | 11 | 0.030 |
Why?
|
| Vascular Fistula | 1 | 2012 | 5 | 0.030 |
Why?
|
| Bradykinin | 1 | 2012 | 18 | 0.030 |
Why?
|
| Catecholamines | 1 | 2012 | 17 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 27 | 0.030 |
Why?
|
| Cell Count | 1 | 2012 | 50 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 332 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 241 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 43 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2013 | 599 | 0.020 |
Why?
|
| Renal Circulation | 1 | 2010 | 13 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2010 | 36 | 0.020 |
Why?
|
| Proteinuria | 1 | 2010 | 57 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 969 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 77 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 310 | 0.020 |
Why?
|
| Pre-Eclampsia | 1 | 2010 | 53 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 17 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2007 | 21 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 815 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1017 | 0.020 |
Why?
|
| DNA | 1 | 2007 | 204 | 0.020 |
Why?
|
| Mutation | 1 | 2007 | 466 | 0.020 |
Why?
|